25 Results for "

HCK kinase

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "HCK kinase" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-112852
CAS No.: 1315330-17-6
Purity:  98.47%
Target:  

Src Apoptosis

Research Areas:  

Cancer

TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM. TL02-59 inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively. TL02-59 potently suppresses acute myelogenous leukemia (AML) cell growth .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18009
CAS No.: 244240-24-2
Research Areas:  

Cancer

LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 μM, 10 μM and 61 μM; LFM-A13 shows no effects on JAK1 and JAK3, Src family kinase HCK, EGFR and IRK.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10185
CAS No.: 867331-64-4
Purity:  98.96%
Target:  

Src VEGFR FGFR PDGFR

Research Areas:  

Inflammation/Immunology

TG 100572 Hydrochloride is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10186
CAS No.: 867331-82-6
Purity:  98.61%
Target:  

VEGFR FGFR PDGFR Src

Research Areas:  

Cancer

TG 100801 is a proagent that generates TG 100572 by de-esterification in development to treat age-related macular degeneration. TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
loading...
    loading...
Cat. No.: HY-123450
CAS No.: 1257628-57-1
Purity:  99.60%
Target:  

Bcr-Abl Apoptosis PDGFR

Research Areas:  

Cancer

S116836, a potent, orally active BCR-ABL tyrosine kinase inhibitor, blocks both wild-type as well as T315I Bcr-Abl. S116836 arrests the cells in the G0/G1 phase of cell cycle, induces apoptosis, increases ROS production, and decreases GSH production in BaF3/WT and BaF3/T315I cells. S116836 also inhibits SRC, LYN, HCK, LCK and BLK, and receptor tyrosine kinases such as FLT3, TIE2, KIT, PDGFR-β. Antitumor activies . S116836 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-120595
CAS No.: 1220626-82-3
Purity:  99.85%
Synonyms: RV568
Target:  

p38 MAPK Src

Research Areas:  

Inflammation/Immunology

JNJ-49095397 (RV568) is an inhaled narrow-spectrum kinase inhibitor (NSKI) against both the α and γ isoforms of p38 MAPK. JNJ-49095397 also inhibits SRC kinase family, specifically haematopoietic kinase (HCK) JNJ-49095397 shows potent anti-inflammatory effects and can be used for the research of chronic obstructive pulmonary disease (COPD) and asthma .
loading...
    loading...
Cat. No.: HY-10184
CAS No.: 867334-05-2
Target:  

Src VEGFR PDGFR FGFR

Research Areas:  

Cancer

TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
loading...
    loading...
Cat. No.: HY-15268
CAS No.: 1092787-12-6
Research Areas:  

Cancer

PP487 is a selective dual inhibitor of Tyrosine kinase/PI3-K, with IC50 values of 0.017 μM, 0.072 μM, 0.004 μM, 0.01 μM, 0.55 μM, 0.22 μM, and < 0.01 μM against DNA-PK, mTOR, Hck, Src, EGFR, EphB4, and PDGFR, respectively. PP487 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-175437
Research Areas:  

Inflammation/Immunology Cancer

MRT-7612 (Compound 4) is a cereblon-based tyrosine kinases molecular glue degrader. MRT-7612 significantly induces HCK and LYN degradation, with week efficacy on LCK. MRT-7612 can be used for cancers like chronic myeloid leukemia, autoimmune and chronic inflammatory diseases research .
loading...
    loading...
Cat. No.: HY-10187
CAS No.: 1018069-81-2
Target:  

VEGFR FGFR PDGFR Src

Research Areas:  

Cancer

TG 100801 Hydrochloride is a proagent that generates TG 100572 by de-esterification in development to treat age-related macular degeneration. TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
loading...
    loading...
Cat. No.: HY-147314
CAS No.: 301357-74-4
Purity:  98.35%
Target:  

HIV Src

Research Areas:  

Infection

HIV-IN-6 is a HIV-Ⅰ viral replication inhibitor by targeting Src family kinases (SFK) that interact with Nef protein of the virus, such as Hck .
loading...
    loading...
Cat. No.: HY-178014
Research Areas:  

Others

SIK1-IN-1 (Compound 27) is a selective Salt-inducible kinase 1 (SIK1) inhibitor with an IC50 of 0.7  nM for SIK1 over SIK2 and SIK3. SIK1-IN-1 has no cytotoxicity against HEK293 cells and PBMCs (maximum concentration of 30 μM). SIK1-IN-1 also has potent inhibitory activities for 392 kinases, in particular tyrosine kinases, such as FGR, HCK and LYN) .
loading...
    loading...
Cat. No.: HY-112852A
CAS No.: 2415263-06-6
Target:  

Src Apoptosis

Research Areas:  

Cancer

TL02-59 dihydrochloride is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM. TL02-59 dihydrochloride inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively. TL02-59 dihydrochloride potently suppresses acute myelogenous leukemia (AML) cell growth .
loading...
    loading...
Cat. No.: HY-135216
CAS No.: 1240322-54-6
Target:  

Src VEGFR Raf EGFR

Research Areas:  

Cancer

Antiproliferative agent-54 (Compound 6z) is the inhibitor for multiple kinases, such as ABL WT, B-RAF, EGFR, HCK, LYN A and SRC with IC50 of 6-50 nM. Antiproliferative agent-54 inhibits proliferation of several cancer cell, inhibits HUVEC and HepG2, with EC50 of 34 and 38 nM. Antiproliferative agent-54 exhibits good pharmacokinetic characteristics in rats .
loading...
    loading...
Cat. No.: HY-18909
CAS No.: 1157857-36-7
Target:  

Src Bcr-Abl Pyk2 p38 MAPK c-Kit

Research Areas:  

Others

Multi-kinase-IN-11 (Compound 1a) is a DFG-out conformation-targeted multi-kinase inhibitor, including SRC, LCK, ABL, PYK2, CSK, HCK, P38 and C-KIT. Multi-kinase-IN-11 serves as a scaffold for the preparation of fluorescently labeled binding probes and affinity matrices .
loading...
    loading...
Cat. No.: HY-P83218
Synonyms: HCK; Tyrosine-protein kinase HCK; Hematopoietic cell kinase; Hemopoietic cell kinase; p59-HCK/p60-HCK; p59HCK; p61HCK

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P85197
Synonyms: HCK; Tyrosine-protein kinase HCK; Hematopoietic cell kinase; Hemopoietic cell kinase; p59-HCK/p60-HCK; p59HCK; p61HCK

Host:  

Mouse

Application:  

IHC-P, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83218A
Synonyms: HCK; Tyrosine-protein kinase HCK; Hematopoietic cell kinase; Hemopoietic cell kinase; p59-HCK/p60-HCK; p59HCK; p61HCK

Host:  

Rabbit

Application:  

WB, ICC/IF, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P706058
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: HCK; P59-HCK/P60-HCK; HCK Proto-Oncogene, Src Family Tyrosine kinase; P59HCK; Hemopoietic Cell kinase; P61HCK; JTK9; Tyrosine-Protein kinase; Tyrosine-Protein kinase HCK; AIPCV; Hematopoietic Cell kinase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701691
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HCK; P59-HCK/P60-HCK; HCK Proto-Oncogene, Src Family Tyrosine kinase; P59HCK; Hemopoietic Cell kinase; P61HCK; JTK9; Tyrosine-Protein kinase; Tyrosine-Protein kinase HCK; AIPCV; Hematopoietic Cell kinase
Species:  
Source:  
loading...
    loading...